QueeZy ER

QueeZy ER is an oral, extended-release fixed-dose combination drug developed and marketed by Jagsonpal Pharmaceuticals for the treatment of nausea and vomiting in pregnancy (NVP), commonly referred to as morning sickness. The formulation contains 20 mg of doxylamine succinate, an H1-antihistamine that blocks histamine receptors to alleviate nausea, and 20 mg of pyridoxine hydrochloride (Vitamin B6), which addresses nutritional deficiencies associated with pregnancy-related emesis. Utilizing a specialized tablet-in-tablet technology, QueeZy ER provides a dual-release profile that offers both immediate and prolonged symptom relief over a 24-hour period. This extended-release formulation is designed to improve patient compliance by reducing the dosing frequency to a single daily tablet, compared to conventional multi-dose regimens. It is approved and launched in India for pregnant women experiencing morning sickness and related symptoms.

Brand names

QueeZy ERQueeZy-ER

Other names

doxylamine succinate + pyridoxine hydrochloride